Lawson Macartney
CIK: 0001606831
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Viking Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 2, 2026VKTX
Viking Therapeutics, Inc.
Award(A)Direct3.2K shares- - Jan 2, 2025VKTX
Viking Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
18.8K shares- - Nov 8, 2024VKTX
Viking Therapeutics, Inc.
Exercise(M)Direct2K shares at avg. $5.80$12K - Nov 8, 2024VKTX
Viking Therapeutics, Inc.
Sale(S)Direct2K shares at avg. $68.67$137K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | Award(A) | 3,150 | - | $0 | Direct |
| Jan 2, 2025 | VKTX Viking Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 18,800 | - | - | Direct |
| Nov 8, 2024 | VKTX Viking Therapeutics, Inc. | Exercise(M) | 2,000 | $5.80 | $11,600 | Direct |
| Nov 8, 2024 | VKTX Viking Therapeutics, Inc. | Sale(S) | 2,000 | $68.67 | $137,333 | Direct |
1-4 of 4 transactions
About MACARTNEY LAWSON
MACARTNEY LAWSON (SEC CIK 0001606831) files insider reports with the SEC as Director of Viking Therapeutics, Inc. (VKTX).
Signal8 holds 3 ownership filings by MACARTNEY LAWSON, all Form 4s, filed between Nov 8, 2024 and Jan 5, 2026. Those filings report 4 transactions, from Nov 8, 2024 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MACARTNEY LAWSON's filings is in SAN DIEGO, CA.
Recent filings by MACARTNEY LAWSON
Other insiders filing for Viking Therapeutics, Inc. (VKTX)
- Kelly-Gemmell Dorothy Elizabeth, Director
- Lian Brian, President & CEO
- ZANTE GREG, Chief Financial Officer
- Mancini Marianna, Chief Operating Officer
- Chen Hubert C, Chief Medical Officer
- Aubuchon Neil William, Chief Commercial Officer